Prostate cancer is one of these diseases, and particularly in patients with its advanced form, the lack of AR expression—either constitutive or induced in AR-positive cells by paracrine IL-1β signaling—might be compounded by the functional inactivation of the AR by ADT/ARIs. The gene discussed is IL1B; the disease is prostate cancer.